Quantum Computing 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Quantum Computing Inc. generated record 3rd quarter 2026 revenue of $9.5 million, compared with $384,000 in the same period last year; Q3 revenue exceeded the $9.2 million generated during the entire first half of 2026.
- Revenue was primarily driven by photonic product sales for aerospace, government, and industrial applications, including contributions from businesses acquired earlier this year.
- Gross profit was $428,000, with a gross margin of 4.5%; operating expenses were $29 million, compared with $10.5 million in the prior-year period.
- Interest and other income was $13 million, compared with $3.5 million a year ago, primarily reflecting interest on larger cash and investment balances.
- QCI reported a net loss of $15.1 million, or $0.07 per basic share, compared with net income of $2.4 million, or $0.01 per basic share, in the prior-year period.
- At quarter end, QCI had approximately $1.3 billion in cash, cash equivalents, and investments, total assets of approximately $1.6 billion, total liabilities of $47.7 million, and contract backlog of approximately $39.1 million.
- As of September 30th, 2026, QCI had approximately $174.3 million in cash and cash equivalents, approximately $1.1 billion in investments, and approximately $916.9 million in working capital.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good day, ladies and gentlemen, and welcome to the Quantum Computing Inc. third quarter 2026 shareholder conference call. At this time, all participants are on a listen-only mode. Following today's prepared remarks, the line will be open for questions. It is now my pleasure to introduce you to your host, David Moskowitz, Head of Investor Relations at QCi.
David, please go ahead. Thank you, operator, and welcome to QCi's third quarter 2026 financial results and business update conference call.
Before we begin, please note that today's remarks include forward-looking statements, including statements about our expected results, plans, strategy, and market opportunities. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. These risks are described in today's press release and in our SEC filings, including our most recent Forms 10-K and 10-Q. These statements speak only as of today, and we undertake no obligation to update them except as required by law. On the call today, we have Dr. Yuping Huang, QCi's Chairman and Chief Executive Officer, and Chris Roberts, our CFO. The team will provide an update on the business, followed by a question-and-answer session. I'll now turn the call over to Yuping.
Please go ahead. Thank you, David.
Good afternoon, everyone, and thank you for joining us. Looking at our third quarter and the year so far, I believe QCi is entering an important new stage. We have spent years building photonic-based quantum technology designed for the real world. Now we are beginning to see our investments come together, and our attention is shifting from what we can build to what we can put to work for customers. That means getting our technologies into customers' hands, delivering on our commitments, and building a business that can grow sustainably. Execution matters more than ever. Our third quarter results reflect progress in that direction. In Q3, we generated record revenue of $9.5 million, led primarily by our expanded photonics business, which serves customers across a range of established markets.
The acquisitions completed this year added established products and customer relationships, as well as manufacturing capabilities essential to our quantum roadmap. That gives us commercial opportunities to grow revenue today while supporting the technologies we are developing for the future. During the quarter, we provided cloud access to our Dirac-3 system to Hamad Bin Khalifa University in Qatar, supporting the research, education, and adoption of quantum computing and networking. That builds on early progress, including the installation of a Dirac-3 optimization system at a leading global consulting firm and an agreement with Planck Dynamics for our NeuraWave reservoir computer in defense applications. More recently, we announced our next-generation Dirac-3S quantum optimization machine, which is designed to solve optimization problems with up to 9,980 variables, an important step in our quantum computing roadmap. We expect the first customer shipment during the fourth quarter.
As a part of the announcement, we published benchmarking results involving problems with up to 9,980 variables, comparing the system's performance with leading classical optimization solvers. We are encouraged by these results and what they tell us about the progress in developing increasingly capable quantum systems. There is still work to do as we evaluate performance across different applications, but advances like these bring us closer to solving larger, more complex problems for customers. These are encouraging developments for sure, but what matters most is what customers can ultimately do with our quantum technology. Our recently announced collaboration with INmune Bio is a good example. Our collaboration with INmune Bio is exploring how Dirac optimization, AI, and conventional analytics could potentially identify new insights for clinical research data.
It is early work, but it reflects what matters most to me, that the true measure of innovation is not just what a technology can do, but what it enables others to achieve. That's exactly the thinking behind the broader platform we are building. Our quantum photonics platform extends beyond computing into sensing and communications as well. Some applications are commercial today, while others need further development and validation. Our manufacturing capabilities connect these opportunities. By combining photonics design, chip manufacturing, and advanced packaging at our North Carolina facility and our thin-film lithium niobate facility in Arizona, we gain greater control over development and production. This infrastructure serves two important purposes: supporting our proprietary quantum systems and serving established photonics markets. The task now is to integrate it effectively and deliver for customers. With that in mind, we are focused on three priorities over the next 12 to 24 months.
The first is growing our commercial business. We have an opportunity to build on the established businesses and customer relationships we have added while expanding the market for our quantum and advanced photonics systems. Our photonics and advanced package businesses provide a commercial foundation we can grow today while supporting the development of our quantum technologies. As those technologies mature, we see opportunities to introduce them to a broader range of customers. Our goal is to turn growing interest in QCi into orders, a stronger backlog, deployments, and lasting customer relationships. Second is to scale manufacturing. We are bringing operations together, expanding capacity, and improving efficiency. Reliable, repeatable production matters as our quantum technologies mature. Our third priority is advancing our quantum portfolio.
We have achieved all the objectives outlined in our 2024 to 2026 portfolio roadmap, so we are moving into the new phase to scale our manufacturing and product lines. Our goal is to make quantum systems smaller, more capable, and easier to deploy. A major part of that work involves integrating more of our technology onto photonic chips, which brings us closer to the compact, practical systems we envision for the future. These three priorities are closely connected. Our quantum roadmap guides the technologies we develop. Our manufacturing capabilities help us bring those technologies into production. Our commercial efforts help us understand where customers see value and where we should focus our resources. It is how we move from building the technology to building a sustainable business around it. That brings me back to something fundamental about QCi and why we have chosen photonics as our approach.
I have believed for many years that light offers one of the most promising paths to making quantum technology practical and accessible. There are several approaches to quantum computing, as we all know, each with its own strengths and challenges. We chose photonics because we believe it offers important advantages in bringing quantum technology into broad real-world use. Our Dirac systems, for example, operate at room temperature with relatively low power requirements and without the specialized cryogenic infrastructure required by many other approaches. That can make a meaningful difference in terms of cost and complexity. Photonics also allows us to build on decades of advances in optical technology and semiconductor manufacturing. With the capabilities we have assembled at QCi, we are bringing more of that process under our own control. This is still considerable work ahead, but I believe this approach gives us a strong foundation for the future.
My ambition has always been to make quantum technology useful and accessible on a much broader scale, and I believe light offers a practical near-term path toward that goal. We are taking the journey one step at a time, and I am encouraged by the progress we have made with our solid Q3 results as evidence. With that, I will turn the call over to Chris to review our third quarter financial results and how we are managing our resources to support the work ahead.
Chris? Thank you, Yuping, and good afternoon, everyone.
I will now review our third quarter financial performance, our balance sheet, and how we are approaching capital allocation as we move into the next phase of QCi's development. Starting with revenue, we generated $9.5 million in the third quarter, up from $384,000 in the same period last year. To put that growth in perspective, our third quarter revenue exceeded the $9.2 million of revenue generated during the entire first half of 2026. Revenue was primarily driven by sales of photonic products serving aerospace, government, and industrial applications. The businesses we acquired earlier this year have expanded our commercial foundation and are contributing to our financial performance while also supporting our longer-term quantum technology roadmap. We generated $428,000 in gross profit during the quarter for a gross margin of 4.5%. While margins remain modest, we are encouraged by the progress.
As revenue grows, we see opportunities to improve manufacturing utilization, increase operating efficiency, and expand margins over time. Turning now to expenses. Our operating expenses totaled $29 million during the quarter compared with $10.5 million in the same period last year. The increase is largely due to higher personnel and related costs associated with our expanded R&D, sales, and marketing activity, as well as approximately $1 million in acquisition-related expenses. Interest and other income totaled $13 million during the third quarter compared with $3.5 million a year ago, primarily reflecting interest earned on our larger cash and investment balances. For the third quarter, we reported a net loss of $15.1 million, or $0.07 per basic share, compared with net income of $2.4 million, or $0.01 per basic share in the prior year period.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
11 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
